Experimental induction of anti-muscarinic type-3-receptor extracellular loop antibodies by immunization with 4-hydroxy-2-nonenal modified Ro60 and unmodified Ro60

Kurien, Biji T
Dave, Devavrat
Tsaliki, Martha
Quadri, Syed M S
Lewis, Valerie M
Scofield, Robert Hal

Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, OK, USA
Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, OK, USA
Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, OK, USA
Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, OK, USA
Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, OK, USA
Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, OK, USA
Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, OK, USA
Departments of Medicine and Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, OK, USA
Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, OK, USA
Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, OK, USA
Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, OK, USA
Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, OK, USA
Departments of Medicine and Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, OK, USA

Correspondence: Robert Hal Scofield, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA. Email: [email protected]

Received May 25, 2024

Received in revised form October 13, 2024

Accepted December 09, 2024

Revised January 21, 2025

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)

Clinical & Experimental Immunology 219(1), 2025. | DOI: 10.1093/cei/uxae114